Summary by Futu AI
Tonix Pharmaceuticals Holding Corp. (Tonix) announced the filing of a preliminary proxy statement with the U.S. Securities and Exchange Commission (SEC) for its upcoming Annual Meeting of Shareholders. The meeting is scheduled to be held virtually on May 22, 2024, at 11:00 a.m. Eastern Daylight Time. Shareholders of record as of March 25, 2024, are entitled to attend, vote, and ask questions during the meeting. The agenda includes the election of eight director nominees, the ratification of EisnerAmper LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024, and the approval of a reverse stock split proposal. Additionally, the meeting will address the approval of the repricing of various series of warrants issued in 2023. The proxy materials will be furnished to shareholders on or about April 16, 2024. The company's CEO and Chairman, Seth Lederman, invites shareholders to attend the virtual meeting and emphasizes the importance of voting by proxy if attendance is not possible.